Abstract

Renal cell carcinoma (RCC) poses a considerable challenge in oncology, both due to its clinical complexity and disparities in treatment access and outcomes among diverse populations. This paper investigates the complex barriers impeding RCC treatment, emphasizing socioeconomic, cultural, and systemic factors that drive inequities in care. Research reveals that marginalized communities frequently encounter obstacles like restricted healthcare access, financial limitations, and insufficient culturally competent care, often resulting in delayed diagnoses, limited treatment options, and poorer outcomes. This review underscores the necessity of recognizing and addressing these barriers to enhance RCC treatment outcomes for all patients. By analyzing existing literature, we identify specific issues such as disparities in health insurance, geographic access, and clinical trial participation. Additionally, we discuss the potential role of healthcare providers in alleviating these barriers through community outreach, patient education, and advocacy for equitable healthcare policies.